Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Design Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DSGN alerts

About Sean Jeffries

Sean Jeffries is recorded as COO at Design Therapeutics, Inc. (DSGN). The newest filing on record that lists Sean Jeffries as COO at Design Therapeutics, Inc. (DSGN) is dated April 23, 2026. The proxy statement of Design Therapeutics, Inc. reports total compensation of $1,891,530 for Sean Jeffries in fiscal 2025, including a base salary of $484,000. Disclosed compensation is on record for 6 fiscal years. Sean Jeffries has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Design Therapeutics, Inc. on May 18, 2026. Design Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Design Therapeutics, Inc. includes Pratik Shah (CEO and Board Member), Pratik Shah, Ph.D. (CEO), Dawn Giangiulio (Chief Accounting Officer) and 7 others.

Sean Jeffries on recent calls

“This presentation will contain forward-looking statements, including statements related to our development plans and other information that is not historical fact.”
COO, Design Therapeutics Conference Call ·
“Earlier, we issued a press release outlining our fourth quarter and full year 2023 financial results and updates across our portfolio of GeneTAC small molecule genomic medicines.”
COO, Design Therapeutics, Inc. Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Design Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Design Therapeutics, Inc. (DSGN) $484,000 $1,891,530
2024 Design Therapeutics, Inc. (DSGN) $432,650 $1,315,002
2023 Design Therapeutics, Inc. (DSGN) $416,010 $1,283,615
2022 Design Therapeutics, Inc. (DSGN) $400,000 $3,429,024
2021 Design Therapeutics, Inc. (DSGN) $340,000 $476,000
2020 Design Therapeutics, Inc. (DSGN) $243,333 $343,333

Recent activity